Chelsea Baker, Neda Rasouli and colleagues, in their recent review paper, ponder if #metformin should remain the first-line therapy for treatment of type 2 #diabetes given recent new medications with CV benefit. bit.ly/2LTiSTx

New article by Neda Rasouli highlighted by Endocrine Society Endocrine Society Journals. Check it out! Vitamin D supplementation improved β-cell function among those with very low baseline 25(OH)D levels (<12 ng/mL). academic.oup.com/jcem/article/1…

Dr Neda Rasouli Neda Rasouli discusses who “deserves” GLP-1 meds. CU Department of Medicine Check out the article below: everydayhealth.com/weight/who-des…